Reports came out earlier this year about investors in Canadian cannabis companies being banned from the U.S. for life. Now, it appears anyone who works in the industry can be turned around at the border.
Cancer patients are sharing their stories to push back on the stigma surrounding the use of cannabis as an adjunct treatment. Many patients and experts believe that clinical trials on the efficacy of medical marijuana as an adjunct cancer treatment need to move faster. Patients are suffering in the interim.